Next Article in Journal
Acknowledgement to Reviewers of Vaccines in 2014
Previous Article in Journal
CD137 Enhancement of HPV Positive Head and Neck Squamous Cell Carcinoma Tumor Clearance
Previous Article in Special Issue
Tumor-Associated Glycans and Immune Surveillance
Article Menu

Export Article

Open AccessArticle
Vaccines 2015, 3(1), 1-19;

The Potential Impact of Preventive HIV Vaccines in China: Results and Benefits of a Multi-Province Modeling Collaboration

International AIDS Vaccine Initiative, 125 Broad St., 9th Floor, New York, NY 10004, USA
Chinese National Center for AIDS/STD Control and Prevention (NCAIDS), Beijing 102206, China
Futures Institute, Glastonbury, CT 06033, USA
Columbia University Global Centers, East Asia, Beijing 100080, China
PATH, Seattle, WA 98121, USA
Center for Disease Control and Prevention of Sichuan Province, Chengdu 610041, China
Joint United Nations Programme for HIV/AIDS (UNAIDS), Geneva CH-1211, Switzerland
Author to whom correspondence should be addressed.
Academic Editor: Diane M. Harper
Received: 15 October 2014 / Accepted: 19 November 2014 / Published: 5 January 2015
(This article belongs to the Special Issue Feature Papers)
Full-Text   |   PDF [604 KB, uploaded 5 January 2015]   |  


China’s commitment to implementing established and emerging HIV/AIDS prevention and control strategies has led to substantial gains in terms of access to antiretroviral treatment and prevention services, but the evolving and multifaceted HIV/AIDS epidemic in China highlights the challenges of maintaining that response. This study presents modeling results exploring the potential impact of HIV vaccines in the Chinese context at varying efficacy and coverage rates, while further exploring the potential implications of vaccination programs aimed at reaching populations at highest risk of HIV infection. A preventive HIV vaccine would add a powerful tool to China’s response, even if not 100% efficacious or available to the full population. View Full-Text
Keywords: HIV/AIDS; vaccines; China; Sichuan; prevention; research; modeling HIV/AIDS; vaccines; China; Sichuan; prevention; research; modeling

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Harmon, T.; Guo, W.; Stover, J.; Wu, Z.; Kaufman, J.; Schneider, K.; Liu, L.; Feng, L.; Schwartländer, B. The Potential Impact of Preventive HIV Vaccines in China: Results and Benefits of a Multi-Province Modeling Collaboration. Vaccines 2015, 3, 1-19.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top